Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 8;15(6):876-879.
doi: 10.2215/CJN.04530420. Epub 2020 Apr 24.

How COVID-19 Has Changed the Management of Glomerular Diseases

Andrew S Bomback  1 , Pietro A Canetta, Wooin Ahn, Syeda B Ahmad, Jai Radhakrishnan, Gerald B Appel
Affiliations

How COVID-19 Has Changed the Management of Glomerular Diseases

Andrew S Bomback et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: COVID-19; glomerular disease; immunosuppression; kidney diseases; severe acute respiratory syndrome coronavirus 2.

PubMed Disclaimer

References

    1. The Columbia University Kidney Transplant Program: Early description of coronavirus 2019 disease in kidney transplant recipients in New York. J Am Soc Nephrol 31: XXX–XXX, 2020 - PMC - PubMed
    1. U.S. Food & Drug Administration : FDA guidance on conduct of clinical trials of medical products during COVID-19 pandemic. Available at: www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-gui.... Accessed April 11, 2020
    1. American College of Rheumatology : ACR infusion guidance during COVID-19 crisis. Available at: www.rheumatology.org/Portals/0/Files/ACR-Infusion-Guidance-COVID-19.pdf. Accessed April 11, 2020
    1. Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC: Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int 95: 429–438, 2019 - PubMed
    1. Danser AHJ, Epstein M, Batlle D: Renin-angiotensin system blockers and the COVID-19 pandemic: At present there is no evidence to abandon renin-angiotensin system blockers [published online ahead of print Mar 25, 2020]. Hypertension doi: 10.1161/HYPERTENSIONAHA.120.15082 - DOI - PMC - PubMed

MeSH terms